Identification of High and Low Responders to Lipopolysaccharide in Normal Subjects: An Unbiased Approach to Identify Modulators of Innate Immunity

LPS stimulates a vigorous inflammatory response from circulating leukocytes that varies greatly from individual to individual. The goal of this study was to use an unbiased approach to identify differences in gene expression that may account for the high degree of interindividual variability in infl...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of immunology (1950) Vol. 175; no. 4; pp. 2570 - 2578
Main Authors Wurfel, Mark M, Park, William Y, Radella, Frank, Ruzinski, John, Sandstrom, Andrew, Strout, Jeanna, Bumgarner, Roger E, Martin, Thomas R
Format Journal Article
LanguageEnglish
Published United States Am Assoc Immnol 15.08.2005
Subjects
Online AccessGet full text

Cover

Loading…
Abstract LPS stimulates a vigorous inflammatory response from circulating leukocytes that varies greatly from individual to individual. The goal of this study was to use an unbiased approach to identify differences in gene expression that may account for the high degree of interindividual variability in inflammatory responses to LPS in the normal human population. We measured LPS-induced cytokine production ex vivo in whole blood from 102 healthy human subjects and identified individuals who consistently showed either very high or very low responses to LPS (denoted lpshigh and lpslow, respectively). Comparison of gene expression profiles between the lpshigh and lpslow individuals revealed 80 genes that were differentially expressed in the presence of LPS and 21 genes that were differentially expressed in the absence of LPS (p < 0.005, ANOVA). Expression of a subset of these genes was confirmed using real-time RT-PCR. Functional relevance for one gene confirmed to be expressed at a higher level in lpshigh, adipophilin, was inferred when reduction in adipophilin mRNA by small interfering RNA in the human monocyte-like cell line THP-1 resulted in a modest but significant reduction in LPS-induced MCP-1 mRNA expression. These data illustrate a novel approach to the identification of factors that determine interindividual variability in innate immune inflammatory responses and identify adipophilin as a novel potential regulator of LPS-induced MCP-1 production in human monocytes.
AbstractList LPS stimulates a vigorous inflammatory response from circulating leukocytes that varies greatly from individual to individual. The goal of this study was to use an unbiased approach to identify differences in gene expression that may account for the high degree of interindividual variability in inflammatory responses to LPS in the normal human population. We measured LPS-induced cytokine production ex vivo in whole blood from 102 healthy human subjects and identified individuals who consistently showed either very high or very low responses to LPS (denoted lpshigh and lpslow, respectively). Comparison of gene expression profiles between the lpshigh and lpslow individuals revealed 80 genes that were differentially expressed in the presence of LPS and 21 genes that were differentially expressed in the absence of LPS (p < 0.005, ANOVA). Expression of a subset of these genes was confirmed using real-time RT-PCR. Functional relevance for one gene confirmed to be expressed at a higher level in lpshigh, adipophilin, was inferred when reduction in adipophilin mRNA by small interfering RNA in the human monocyte-like cell line THP-1 resulted in a modest but significant reduction in LPS-induced MCP-1 mRNA expression. These data illustrate a novel approach to the identification of factors that determine interindividual variability in innate immune inflammatory responses and identify adipophilin as a novel potential regulator of LPS-induced MCP-1 production in human monocytes.
LPS stimulates a vigorous inflammatory response from circulating leukocytes that varies greatly from individual to individual. The goal of this study was to use an unbiased approach to identify differences in gene expression that may account for the high degree of interindividual variability in inflammatory responses to LPS in the normal human population. We measured LPS-induced cytokine production ex vivo in whole blood from 102 healthy human subjects and identified individuals who consistently showed either very high or very low responses to LPS (denoted lps sub(high) and lps sub(low), respectively). Comparison of gene expression profiles between the lps sub(high) and lps sub(low) individuals revealed 80 genes that were differentially expressed in the presence of LPS and 21 genes that were differentially expressed in the absence of LPS (p < 0.005, ANOVA). Expression of a subset of these genes was confirmed using real-time RT-PCR. Functional relevance for one gene confirmed to be expressed at a higher level in lps sub(high), adipophilin, was inferred when reduction in adipophilin mRNA by small interfering RNA in the human monocyte-like cell line THP-1 resulted in a modest but significant reduction in LPS-induced MCP-1 mRNA expression. These data illustrate a novel approach to the identification of factors that determine interindividual variability in innate immune inflammatory responses and identify adipophilin as a novel potential regulator of LPS-induced MCP-1 production in human monocytes.
LPS stimulates a vigorous inflammatory response from circulating leukocytes that varies greatly from individual to individual. The goal of this study was to use an unbiased approach to identify differences in gene expression that may account for the high degree of interindividual variability in inflammatory responses to LPS in the normal human population. We measured LPS-induced cytokine production ex vivo in whole blood from 102 healthy human subjects and identified individuals who consistently showed either very high or very low responses to LPS (denoted lps(high) and lps(low), respectively). Comparison of gene expression profiles between the lps(high) and lps(low) individuals revealed 80 genes that were differentially expressed in the presence of LPS and 21 genes that were differentially expressed in the absence of LPS (p < 0.005, ANOVA). Expression of a subset of these genes was confirmed using real-time RT-PCR. Functional relevance for one gene confirmed to be expressed at a higher level in lps(high), adipophilin, was inferred when reduction in adipophilin mRNA by small interfering RNA in the human monocyte-like cell line THP-1 resulted in a modest but significant reduction in LPS-induced MCP-1 mRNA expression. These data illustrate a novel approach to the identification of factors that determine interindividual variability in innate immune inflammatory responses and identify adipophilin as a novel potential regulator of LPS-induced MCP-1 production in human monocytes.
LPS stimulates a vigorous inflammatory response from circulating leukocytes that varies greatly from individual to individual. The goal of this study was to use an unbiased approach to identify differences in gene expression that may account for the high degree of interindividual variability in inflammatory responses to LPS in the normal human population. We measured LPS-induced cytokine production ex vivo in whole blood from 102 healthy human subjects and identified individuals who consistently showed either very high or very low responses to LPS (denoted lps(high) and lps(low), respectively). Comparison of gene expression profiles between the lps(high) and lps(low) individuals revealed 80 genes that were differentially expressed in the presence of LPS and 21 genes that were differentially expressed in the absence of LPS (p < 0.005, ANOVA). Expression of a subset of these genes was confirmed using real-time RT-PCR. Functional relevance for one gene confirmed to be expressed at a higher level in lps(high), adipophilin, was inferred when reduction in adipophilin mRNA by small interfering RNA in the human monocyte-like cell line THP-1 resulted in a modest but significant reduction in LPS-induced MCP-1 mRNA expression. These data illustrate a novel approach to the identification of factors that determine interindividual variability in innate immune inflammatory responses and identify adipophilin as a novel potential regulator of LPS-induced MCP-1 production in human monocytes.LPS stimulates a vigorous inflammatory response from circulating leukocytes that varies greatly from individual to individual. The goal of this study was to use an unbiased approach to identify differences in gene expression that may account for the high degree of interindividual variability in inflammatory responses to LPS in the normal human population. We measured LPS-induced cytokine production ex vivo in whole blood from 102 healthy human subjects and identified individuals who consistently showed either very high or very low responses to LPS (denoted lps(high) and lps(low), respectively). Comparison of gene expression profiles between the lps(high) and lps(low) individuals revealed 80 genes that were differentially expressed in the presence of LPS and 21 genes that were differentially expressed in the absence of LPS (p < 0.005, ANOVA). Expression of a subset of these genes was confirmed using real-time RT-PCR. Functional relevance for one gene confirmed to be expressed at a higher level in lps(high), adipophilin, was inferred when reduction in adipophilin mRNA by small interfering RNA in the human monocyte-like cell line THP-1 resulted in a modest but significant reduction in LPS-induced MCP-1 mRNA expression. These data illustrate a novel approach to the identification of factors that determine interindividual variability in innate immune inflammatory responses and identify adipophilin as a novel potential regulator of LPS-induced MCP-1 production in human monocytes.
Author Park, William Y
Ruzinski, John
Strout, Jeanna
Martin, Thomas R
Radella, Frank
Wurfel, Mark M
Sandstrom, Andrew
Bumgarner, Roger E
Author_xml – sequence: 1
  fullname: Wurfel, Mark M
– sequence: 2
  fullname: Park, William Y
– sequence: 3
  fullname: Radella, Frank
– sequence: 4
  fullname: Ruzinski, John
– sequence: 5
  fullname: Sandstrom, Andrew
– sequence: 6
  fullname: Strout, Jeanna
– sequence: 7
  fullname: Bumgarner, Roger E
– sequence: 8
  fullname: Martin, Thomas R
BackLink https://www.ncbi.nlm.nih.gov/pubmed/16081831$$D View this record in MEDLINE/PubMed
BookMark eNqFkc1u1DAUhS1URKctT4CEvIJVBjt2nITdqKLtSANI0K4tj38YjxI72I6ieY0-cR1mihALWF3J-s651-dcgDPnnQbgDUZLimj7YW_7fnS-W-K6WtJlWdXoBVjgqkIFY4idgQVCZVngmtXn4CLGPUKIoZK-AueYoQY3BC_A41ppl6yxUiTrHfQG3tkfOyicghs_wW86Dt4pHSJMHm7s4AffHaKQcieCVRpaB7_40IsOfh-3ey1T_AhXDj64rRVRK7gahuCF3M3y064D_OzV2Inks2teuHZOJA3X83dsOlyBl0Z0Ub8-zUvwcPPp_vqu2Hy9XV-vNoWkGKeiVUwpgZRBLA_dSlMjQxBr2poaIhvJqNAMaUM0IVW9JSQ_NG2pTFWKRpXkErw7-uYDf446Jt7bKHXXCaf9GDlrKG1ZVf8XzPm3VYtoBt-ewHHba8WHYHsRDvw57gy0R0AGH2PQhkubfgWfgrAdx4jP1fLnamdrTvlcbdaSv7S_7f-pen9U7XKrkw2ax9xVlw_EfJqmP8gnHgC6fQ
CitedBy_id crossref_primary_10_2310_JIM_0b013e3181891560
crossref_primary_10_1016_j_physbeh_2016_11_012
crossref_primary_10_1042_CS20070214
crossref_primary_10_1371_journal_pone_0081617
crossref_primary_10_1186_s12865_022_00534_z
crossref_primary_10_1186_1465_9921_8_64
crossref_primary_10_1016_j_toxrep_2017_10_004
crossref_primary_10_1111_anae_13868
crossref_primary_10_1016_j_coi_2014_06_002
crossref_primary_10_1177_1099800416629209
crossref_primary_10_1016_j_tem_2024_04_004
crossref_primary_10_1007_s11010_009_0299_7
crossref_primary_10_1371_journal_pone_0117261
crossref_primary_10_1155_2014_293925
crossref_primary_10_3168_jds_2011_4288
crossref_primary_10_1002_JLB_4MA0320_544RR
crossref_primary_10_1016_j_vetimm_2010_10_006
crossref_primary_10_1016_j_jprot_2024_105232
crossref_primary_10_3349_ymj_2016_57_1_111
crossref_primary_10_1111_j_1365_2249_2006_03074_x
crossref_primary_10_1177_01926233231190382
crossref_primary_10_1165_rcmb_2010_0342OC
crossref_primary_10_1164_rccm_201307_1208ED
crossref_primary_10_1099_vir_0_038414_0
crossref_primary_10_1016_j_rvsc_2012_09_019
crossref_primary_10_1016_j_cell_2012_08_043
crossref_primary_10_3389_fimmu_2020_569331
crossref_primary_10_2217_imt_2019_0096
crossref_primary_10_3390_cells10123279
crossref_primary_10_1007_s00204_008_0290_1
crossref_primary_10_1016_j_molmed_2005_11_002
crossref_primary_10_1371_journal_pone_0013759
crossref_primary_10_1371_journal_pone_0008583
crossref_primary_10_1016_j_jim_2013_08_006
crossref_primary_10_1186_1471_2288_12_112
crossref_primary_10_4049_jimmunol_177_11_8086
crossref_primary_10_1016_j_jnutbio_2011_03_004
crossref_primary_10_1016_j_ajog_2009_05_012
crossref_primary_10_1097_SHK_0000000000001915
crossref_primary_10_1369_00221554211054447
crossref_primary_10_1515_CCLM_2007_035
crossref_primary_10_1002_eji_200737034
crossref_primary_10_1097_01_CCM_0000220051_19432_05
crossref_primary_10_1016_j_taap_2008_01_033
crossref_primary_10_2310_JIM_0b013e31829cbd14
crossref_primary_10_4049_jimmunol_1103319
crossref_primary_10_1016_j_jpurol_2017_05_025
crossref_primary_10_1152_ajplung_00139_2007
crossref_primary_10_1016_j_ccc_2011_05_013
crossref_primary_10_1172_JCI86802
crossref_primary_10_1371_journal_pone_0028768
crossref_primary_10_1088_0022_3727_47_22_224015
crossref_primary_10_1007_s00011_022_01543_9
crossref_primary_10_1016_j_heares_2006_05_012
crossref_primary_10_1002_ppap_201200087
crossref_primary_10_1086_674439
crossref_primary_10_4049_jimmunol_0903463
crossref_primary_10_1089_sur_2009_018
crossref_primary_10_1111_j_1365_2567_2008_02915_x
crossref_primary_10_3389_fimmu_2020_577823
crossref_primary_10_3389_fimmu_2022_871780
crossref_primary_10_1016_j_mtbio_2020_100080
crossref_primary_10_1128_MMBR_05015_11
crossref_primary_10_1073_pnas_0706097104
crossref_primary_10_1080_15321819_2015_1047516
crossref_primary_10_1371_journal_pone_0188881
crossref_primary_10_1016_S2213_2600_21_00157_0
crossref_primary_10_1038_mi_2012_139
crossref_primary_10_1111_j_1365_2567_2008_02907_x
crossref_primary_10_1158_1078_0432_CCR_16_2199
crossref_primary_10_1016_j_celrep_2020_108590
crossref_primary_10_1016_j_autneu_2019_102580
crossref_primary_10_1177_0192623309343778
crossref_primary_10_1080_13547500601160536
crossref_primary_10_1016_j_bbih_2020_100080
crossref_primary_10_1164_rccm_200803_462OC
crossref_primary_10_1007_s12026_015_8640_6
crossref_primary_10_1086_590440
crossref_primary_10_1097_CCM_0b013e31819c14fa
crossref_primary_10_1016_j_suc_2008_09_004
crossref_primary_10_1016_j_bbi_2016_10_003
crossref_primary_10_1038_s41398_021_01359_x
crossref_primary_10_1002_art_27325
crossref_primary_10_1002_dta_1973
crossref_primary_10_1097_CCM_0b013e31819d2daa
crossref_primary_10_1097_01_shk_0000232589_39001_4d
crossref_primary_10_1186_gb_2010_11_1_r3
crossref_primary_10_1038_s41390_022_02153_1
crossref_primary_10_1371_journal_pone_0135527
crossref_primary_10_1002_ptr_4678
crossref_primary_10_1371_journal_pone_0097702
crossref_primary_10_1186_s13567_018_0616_9
crossref_primary_10_3168_jds_2008_1954
crossref_primary_10_1038_gene_2012_53
Cites_doi 10.1074/jbc.M100099200
10.1038/sj.gene.6363979
10.1006/cyto.1998.0471
10.1056/NEJM200103083441001
10.1073/pnas.022649799
10.1378/chest.126.1.95
10.1084/jem.20030701
10.1016/S0022-1759(98)00108-2
10.5551/jat.11.88
10.4049/jimmunol.172.8.4977
10.1126/science.1081902
10.1189/jlb.0203082
10.1002/eji.1830191222
10.1152/jappl.1991.71.5.1979
10.1016/j.jpeds.2003.10.034
10.1161/01.ATV.0000115638.27381.97
10.1126/science.3895437
10.1084/jem.172.1.77
10.1097/00003246-200205000-00003
10.4049/jimmunol.170.7.3451
10.1016/S0006-2952(98)00105-1
10.1001/archinte.162.9.1028
10.1006/brbi.1999.0570
10.1182/blood.V99.10.3524
10.1038/nature02623
10.1006/scdb.1998.0275
10.1002/jlb.56.1.1
10.1084/jem.20031220
10.1016/0090-1229(88)90130-4
10.1097/00003246-200103000-00015
10.1182/blood-2002-10-3232
10.1016/S1388-1981(01)00121-4
10.1086/379044
10.1086/375744
10.4049/jimmunol.169.1.10
10.1111/j.1432-1033.1992.tb16999.x
10.1006/cyto.1996.0155
10.1073/pnas.89.17.7856
10.1016/S0022-2275(20)34939-7
10.1038/330662a0
10.1073/pnas.231625398
10.1038/3327
10.1126/science.1099870
10.1016/S0014-5793(99)01521-5
10.1001/jama.263.7.937
10.1182/blood.V89.11.4182
10.1111/j.1432-1033.1991.tb16139.x
10.1073/pnas.1031605100
10.1101/gr.6.10.995
10.1016/S0092-8674(00)00015-5
10.1038/sj.onc.1201206
10.1097/00003246-200103000-00006
10.1086/344893
ContentType Journal Article
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7T5
H94
7X8
DOI 10.4049/jimmunol.175.4.2570
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Immunology Abstracts
AIDS and Cancer Research Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
AIDS and Cancer Research Abstracts
Immunology Abstracts
MEDLINE - Academic
DatabaseTitleList CrossRef
AIDS and Cancer Research Abstracts
MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1550-6606
EndPage 2578
ExternalDocumentID 16081831
10_4049_jimmunol_175_4_2570
www175_4_2570
Genre Research Support, U.S. Gov't, Non-P.H.S
Research Support, U.S. Gov't, P.H.S
Comparative Study
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: PHS HHS
  grantid: K23 62-9063
– fundername: NHLBI NIH HHS
  grantid: 1 P50 HL073996-01
– fundername: NIAID NIH HHS
  grantid: U54 AI057141
GroupedDBID -
08R
2WC
34G
39C
3O-
53G
55
5GY
5RE
5VS
79B
85S
8RP
AALRV
AARDX
ABEFU
ABFLS
ABOCM
ABPPZ
ABPTK
ACGFS
ACIWK
ACNCT
ACPRK
ADACO
ADBBV
ADKFC
AENEX
AETEA
AFFNX
AFRAH
AJYGW
ALMA_UNASSIGNED_HOLDINGS
BAWUL
D0L
DIK
DU5
E3Z
EBS
EJD
F5P
FH7
FRP
G8K
GJ
GX1
H13
IH2
J5H
K-O
K78
KQ8
L7B
MVM
MYA
NEJ
O0-
OK1
P0W
P2P
PQEST
PQQKQ
R.V
RHF
RHI
RZQ
SJN
TWZ
VH1
WH7
WOQ
X
X7M
XJT
ZA5
ZE2
ZGI
---
-~X
.55
.GJ
0R~
18M
5WD
AAYXX
ABCQX
ABDFA
ABDPE
ABEJV
ABGNP
ABJNI
ABXVV
ACGFO
ADIPN
ADNWM
ADXHL
AFHIN
AFOSN
AGORE
AHMMS
AHWXS
AI.
AIZAD
ARBBW
BCRHZ
BTFSW
CITATION
OCZFY
OWPYF
ROX
TR2
W8F
XSW
XTH
YHG
CGR
CUY
CVF
ECM
EIF
NPM
VXZ
YIN
7T5
H94
7X8
ID FETCH-LOGICAL-c411t-9d6dda0df06da0e9cf70f3068974f3c8c64ae60ef3e3357b3364a892df52a8d23
ISSN 0022-1767
IngestDate Fri Jul 11 06:48:36 EDT 2025
Tue Aug 05 10:50:39 EDT 2025
Wed Feb 19 02:35:24 EST 2025
Tue Jul 01 01:03:24 EDT 2025
Thu Apr 24 23:09:54 EDT 2025
Tue Nov 10 19:50:36 EST 2020
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c411t-9d6dda0df06da0e9cf70f3068974f3c8c64ae60ef3e3357b3364a892df52a8d23
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
OpenAccessLink https://journals.aai.org/jimmunol/article-pdf/175/4/2570/1207102/2570.pdf
PMID 16081831
PQID 17595904
PQPubID 23462
PageCount 9
ParticipantIDs proquest_miscellaneous_68449657
proquest_miscellaneous_17595904
pubmed_primary_16081831
crossref_citationtrail_10_4049_jimmunol_175_4_2570
crossref_primary_10_4049_jimmunol_175_4_2570
highwire_smallpub1_www175_4_2570
ProviderPackageCode RHF
RHI
CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2005-08-15
PublicationDateYYYYMMDD 2005-08-15
PublicationDate_xml – month: 08
  year: 2005
  text: 2005-08-15
  day: 15
PublicationDecade 2000
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle The Journal of immunology (1950)
PublicationTitleAlternate J Immunol
PublicationYear 2005
Publisher Am Assoc Immnol
Publisher_xml – name: Am Assoc Immnol
References 2023010121130924400_R8
2023010121130924400_R37
2023010121130924400_R9
2023010121130924400_R38
2023010121130924400_R6
2023010121130924400_R35
2023010121130924400_R7
2023010121130924400_R36
2023010121130924400_R4
2023010121130924400_R33
2023010121130924400_R5
2023010121130924400_R34
2023010121130924400_R2
2023010121130924400_R31
2023010121130924400_R3
2023010121130924400_R32
2023010121130924400_R1
2023010121130924400_R30
2023010121130924400_R28
2023010121130924400_R29
2023010121130924400_R48
2023010121130924400_R49
2023010121130924400_R46
2023010121130924400_R47
2023010121130924400_R44
2023010121130924400_R45
2023010121130924400_R42
2023010121130924400_R43
2023010121130924400_R40
2023010121130924400_R41
2023010121130924400_R39
2023010121130924400_R15
2023010121130924400_R16
2023010121130924400_R13
2023010121130924400_R14
2023010121130924400_R11
2023010121130924400_R12
2023010121130924400_R53
2023010121130924400_R10
2023010121130924400_R54
2023010121130924400_R51
2023010121130924400_R52
2023010121130924400_R50
2023010121130924400_R26
2023010121130924400_R27
2023010121130924400_R24
2023010121130924400_R25
2023010121130924400_R22
2023010121130924400_R23
2023010121130924400_R20
2023010121130924400_R21
2023010121130924400_R19
2023010121130924400_R17
2023010121130924400_R18
J Immunol. 2006 Feb 15;176(4):2669
References_xml – ident: 2023010121130924400_R53
  doi: 10.1074/jbc.M100099200
– ident: 2023010121130924400_R31
  doi: 10.1038/sj.gene.6363979
– ident: 2023010121130924400_R16
  doi: 10.1006/cyto.1998.0471
– ident: 2023010121130924400_R2
  doi: 10.1056/NEJM200103083441001
– ident: 2023010121130924400_R22
  doi: 10.1073/pnas.022649799
– ident: 2023010121130924400_R30
  doi: 10.1378/chest.126.1.95
– ident: 2023010121130924400_R37
  doi: 10.1084/jem.20030701
– ident: 2023010121130924400_R15
  doi: 10.1016/S0022-1759(98)00108-2
– ident: 2023010121130924400_R52
  doi: 10.5551/jat.11.88
– ident: 2023010121130924400_R23
  doi: 10.4049/jimmunol.172.8.4977
– ident: 2023010121130924400_R36
  doi: 10.1126/science.1081902
– ident: 2023010121130924400_R5
  doi: 10.1189/jlb.0203082
– ident: 2023010121130924400_R18
  doi: 10.1002/eji.1830191222
– ident: 2023010121130924400_R8
  doi: 10.1152/jappl.1991.71.5.1979
– ident: 2023010121130924400_R38
  doi: 10.1016/j.jpeds.2003.10.034
– ident: 2023010121130924400_R26
  doi: 10.1161/01.ATV.0000115638.27381.97
– ident: 2023010121130924400_R6
  doi: 10.1126/science.3895437
– ident: 2023010121130924400_R10
  doi: 10.1084/jem.172.1.77
– ident: 2023010121130924400_R39
  doi: 10.1097/00003246-200205000-00003
– ident: 2023010121130924400_R33
  doi: 10.4049/jimmunol.170.7.3451
– ident: 2023010121130924400_R25
  doi: 10.1016/S0006-2952(98)00105-1
– ident: 2023010121130924400_R42
  doi: 10.1001/archinte.162.9.1028
– ident: 2023010121130924400_R9
  doi: 10.1006/brbi.1999.0570
– ident: 2023010121130924400_R32
  doi: 10.1182/blood.V99.10.3524
– ident: 2023010121130924400_R4
  doi: 10.1038/nature02623
– ident: 2023010121130924400_R50
  doi: 10.1006/scdb.1998.0275
– ident: 2023010121130924400_R14
  doi: 10.1002/jlb.56.1.1
– ident: 2023010121130924400_R35
  doi: 10.1084/jem.20031220
– ident: 2023010121130924400_R19
  doi: 10.1016/0090-1229(88)90130-4
– ident: 2023010121130924400_R40
  doi: 10.1097/00003246-200103000-00015
– ident: 2023010121130924400_R24
  doi: 10.1182/blood-2002-10-3232
– ident: 2023010121130924400_R27
  doi: 10.1016/S1388-1981(01)00121-4
– ident: 2023010121130924400_R41
  doi: 10.1086/379044
– ident: 2023010121130924400_R29
  doi: 10.1086/375744
– ident: 2023010121130924400_R28
  doi: 10.4049/jimmunol.169.1.10
– ident: 2023010121130924400_R46
  doi: 10.1111/j.1432-1033.1992.tb16999.x
– ident: 2023010121130924400_R20
  doi: 10.1006/cyto.1996.0155
– ident: 2023010121130924400_R48
  doi: 10.1073/pnas.89.17.7856
– ident: 2023010121130924400_R17
– ident: 2023010121130924400_R51
  doi: 10.1016/S0022-2275(20)34939-7
– ident: 2023010121130924400_R7
  doi: 10.1038/330662a0
– ident: 2023010121130924400_R21
  doi: 10.1073/pnas.231625398
– ident: 2023010121130924400_R12
  doi: 10.1038/3327
– ident: 2023010121130924400_R44
  doi: 10.1126/science.1099870
– ident: 2023010121130924400_R49
  doi: 10.1016/S0014-5793(99)01521-5
– ident: 2023010121130924400_R1
  doi: 10.1001/jama.263.7.937
– ident: 2023010121130924400_R54
  doi: 10.1182/blood.V89.11.4182
– ident: 2023010121130924400_R45
  doi: 10.1111/j.1432-1033.1991.tb16139.x
– ident: 2023010121130924400_R34
  doi: 10.1073/pnas.1031605100
– ident: 2023010121130924400_R13
  doi: 10.1101/gr.6.10.995
– ident: 2023010121130924400_R11
  doi: 10.1016/S0092-8674(00)00015-5
– ident: 2023010121130924400_R47
  doi: 10.1038/sj.onc.1201206
– ident: 2023010121130924400_R3
  doi: 10.1097/00003246-200103000-00006
– ident: 2023010121130924400_R43
  doi: 10.1086/344893
– reference: - J Immunol. 2006 Feb 15;176(4):2669
SSID ssj0006024
Score 2.1749167
Snippet LPS stimulates a vigorous inflammatory response from circulating leukocytes that varies greatly from individual to individual. The goal of this study was to...
SourceID proquest
pubmed
crossref
highwire
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 2570
SubjectTerms Adolescent
Adult
Aged
Analysis of Variance
Cell Line, Tumor
Chemokine CCL2 - biosynthesis
Chemokine CCL2 - genetics
Cytokines - biosynthesis
Cytokines - blood
Cytokines - genetics
Cytokines - physiology
Dose-Response Relationship, Immunologic
Female
Gene Expression Profiling - methods
Gene Expression Profiling - standards
Gene Expression Profiling - statistics & numerical data
Humans
Immunity, Innate - genetics
Immunophenotyping
Inflammation Mediators - blood
Inflammation Mediators - metabolism
Inflammation Mediators - physiology
Lipopolysaccharides - pharmacology
Male
Membrane Proteins - biosynthesis
Membrane Proteins - physiology
Middle Aged
Perilipin-2
RNA, Messenger - biosynthesis
Title Identification of High and Low Responders to Lipopolysaccharide in Normal Subjects: An Unbiased Approach to Identify Modulators of Innate Immunity
URI http://www.jimmunol.org/cgi/content/abstract/175/4/2570
https://www.ncbi.nlm.nih.gov/pubmed/16081831
https://www.proquest.com/docview/17595904
https://www.proquest.com/docview/68449657
Volume 175
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKEIgXBONWrn6Ap9GS2M6Ntwk2bdAVNLVib1Yax6KoSqc1VdX9DH4BP5VzYjtJRcftoWkUOXaa76t9zvG5EPJSpBHjaZb1EpXEoKCIoJdo7fVSnymfMV-pGAOFT4bh0Vh8OAvOOp0fLa-lZTnpZ5db40r-B1W4BrhilOw_IFt3ChfgHPCFIyAMx7_C2ETZamt2q2zyoGtX-wGDOdr90f8VPZVRwhxMz7EgwnoB7-wraMiqShcyRJl1hvMHGmQW1k44LiZTWN4UCql1yJUdbY3107DoF5bpqQJRCpBX946rQJNyY5e4iTszqSmwicn59KraWfNadogvywttPAYwfKgx0n62ztzWMLRXi96nmOByljrpu444Ol1e1tW4a0djZ9cI0FBrIjtbcQZ-ZIp11HN1FLRIKdozb2AKkNhVHGeibSsEsBETrH6zv7gPHfZFv7m5nY97-EkejgcDOTo4G10j1xkoIlgj4_3xx3qtDz0mXD56fFaT1woHebNliE3Zx-Wjvlq3qWSc0R1y20JF9w3T7pJOXuySG6Zc6XqX3Dyxjhj3yPdN6tG5pkg9CtSjQD3aUI-Wc_or9ei0oIZ61FHvLd0vqCMedcTD2x3xaEM8HNAQjzri3Sfjw4PRu6OeLe_Ry4TvlzA7hEqlntJeCF95kunI06DBxqDiap7FWSjSPPRyzXPOg2jCOVyIE6Z0wNJYMf6A7BTzIn9EKEhcWngcPr4S-USlPAtR12GeyMJA5V3C3IuXmc19jyVYZhJ0YERLOrQkoCWFRLS65HV907lJ_fL75tQhKhfw-maApC9Xq1W7yQuHtIRZHLfm0iKfLxfYTRIknri6RRgLLO0QdclDQ5HmmUJMS8n9x3_s_Qm51fzTnpKd8mKZPwOZupw8r2j9E1l70rk
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Identification+of+High+and+Low+Responders+to+Lipopolysaccharide+in+Normal+Subjects%3A+An+Unbiased+Approach+to+Identify+Modulators+of+Innate+Immunity&rft.jtitle=The+Journal+of+immunology+%281950%29&rft.au=Wurfel%2C+Mark+M&rft.au=Park%2C+William+Y&rft.au=Radella%2C+Frank&rft.au=Ruzinski%2C+John&rft.date=2005-08-15&rft.issn=0022-1767&rft.volume=175&rft.issue=4&rft.spage=2570&rft.epage=2578&rft_id=info:doi/10.4049%2Fjimmunol.175.4.2570&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-1767&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-1767&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-1767&client=summon